SIMONCELLI, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 251
NA - Nord America 97
AS - Asia 34
SA - Sud America 3
Totale 385
Nazione #
US - Stati Uniti d'America 97
IE - Irlanda 83
IT - Italia 68
RU - Federazione Russa 31
CN - Cina 15
SE - Svezia 14
SG - Singapore 14
GB - Regno Unito 13
FR - Francia 12
DE - Germania 10
FI - Finlandia 7
CZ - Repubblica Ceca 4
NL - Olanda 3
BO - Bolivia 2
MY - Malesia 2
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
LT - Lituania 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 385
Città #
Dublin 82
Ashburn 25
Siena 17
Chandler 16
Florence 14
Singapore 13
New York 10
Shanghai 10
Southend 7
Fremont 5
Helsinki 5
Princeton 5
Milan 4
Rome 4
Washington 4
Bitetto 2
Brno 2
Fairfield 2
Frankfurt am Main 2
Kilburn 2
Lappeenranta 2
London 2
Messina 2
Moscow 2
Turin 2
Athens 1
Bologna 1
Bolzano 1
Bratislava 1
Chiswick 1
Como 1
Friesland 1
Groningen 1
Henderson 1
Islamabad 1
Jinan 1
La Paz 1
Lastra a Signa 1
Lisbon 1
Los Angeles 1
Málaga 1
Olomouc 1
Parma 1
Prad am Stilfser Joch 1
Riyadh 1
Sacramento 1
San Diego 1
Southwark 1
Sucre 1
Verona 1
Zanjan 1
Zhoukou 1
Zurich 1
Totale 269
Nome #
Anti CD38 monoclonal antibodies for multiple myeloma treatment 80
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 79
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 71
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 59
Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumor cells 34
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 33
Functional imaging in the evaluation of treatment response in multiple myeloma: the role of PET-CT and MRI 32
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study 24
Totale 412
Categoria #
all - tutte 2.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202234 0 0 0 0 0 0 0 0 3 6 14 11
2022/2023126 4 12 15 11 9 13 11 11 7 2 31 0
2023/2024176 5 4 19 12 9 47 57 4 3 6 3 7
2024/202576 12 6 31 20 7 0 0 0 0 0 0 0
Totale 412